Combined use of serum ferritin and KL-6 levels as biomarkers for predicting COVID-19 severity.
Tanaka H, Toya E, Chubachi S, Namkoong H, Asakura T, Azekawa S, Otake S, Nakagawara K, Fukushima T, Watase M, Sakurai K, Masaki K, Kamata H, Ishii M, Hasegawa N, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K.
Tanaka H, et al. Among authors: sakurai k.
Respir Investig. 2024 Oct 3;62(6):1132-1136. doi: 10.1016/j.resinv.2024.09.011. Online ahead of print.
Respir Investig. 2024.
PMID: 39366121
Free article.